OpenURL Connection Search

Select item for more details and to access through your institution.

Faecal bacterial mass and energetic losses in healthy humans and patients with a short bowel syndrome.
Published in:
European Journal of Clinical Nutrition, 2007, v. 61, n. 2, p. 233, doi. 10.1038/sj.ejcn.1602496
By:
- Achour, L.;
- Nancey, S.;
- Moussata, D.;
- Graber, I.;
- Messing, B.;
- Flourié, B.
Publication type:
Article
Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
Published in:
Digestive Diseases & Sciences, 2022, v. 67, n. 6, p. 2492, doi. 10.1007/s10620-021-07074-3
By:
- Servais, L.;
- Boschetti, G.;
- Meunier, C.;
- Gay, C.;
- Cotte, E.;
- François, Y.;
- Rozieres, A.;
- Fontaine, J.;
- Cuminal, L.;
- Chauvenet, M.;
- Charlois, A. L.;
- Isaac, S.;
- Traverse-Glehen, A.;
- Roblin, X.;
- Flourié, B.;
- Valette, P. J.;
- Nancey, S.
Publication type:
Article
Intact autophagic flux in a TTC7A loss of function model.
Published in:
Journal of Pediatric Gastroenterology & Nutrition, 2022, v. 74, p. 123, doi. 10.1097/MPG.0000000000003446
By:
- Verdenet, A.;
- Rozières, A.;
- Boschetti, G.;
- Nancey, S.;
- Viret, C.;
- Muise, A.;
- Faure, M.;
- Duclaux- Loras, R.
Publication type:
Article
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.
Published in:
2017
By:
- Venturin, C.;
- Nancey, S.;
- Danion, P.;
- Uzzan, M.;
- Chauvenet, M.;
- Bergoin, C.;
- Roblin, X.;
- Flourié, B.;
- Boschetti, G.
Publication type:
journal article
Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 906, doi. 10.1111/apt.14548
By:
- Yacoub, W.;
- Williet, N.;
- Pouillon, L.;
- Di‐Bernado, T.;
- De Carvalho Bittencourt, M.;
- Nancey, S.;
- Lopez, A.;
- Paul, S.;
- Zallot, C.;
- Roblin, X.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 485, doi. 10.1111/apt.14419
By:
- Tadbiri, S.;
- Peyrin‐Biroulet, L.;
- Serrero, M.;
- Filippi, J.;
- Pariente, B.;
- Roblin, X.;
- Buisson, A.;
- Stefanescu, C.;
- Trang‐Poisson, C.;
- Altwegg, R.;
- Marteau, P.;
- Vaysse, T.;
- Bourrier, A.;
- Nancey, S.;
- Laharie, D.;
- Allez, M.;
- Savoye, G.;
- Gilletta, C.;
- Gagniere, C.;
- Vuitton, L.
Publication type:
Article
Letter: thiopurines - is less really more? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 1, p. 150, doi. 10.1111/apt.14385
By:
- Roblin, X.;
- Paul, S.;
- Nancey, S.;
- Flourie, B.
Publication type:
Article
Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1077, doi. 10.1111/apt.14371
By:
- Martineau, C.;
- Flourié, B.;
- Wils, P.;
- Vaysse, T.;
- Altwegg, R.;
- Buisson, A.;
- Amiot, A.;
- Pineton de Chambrun, G.;
- Abitbol, V.;
- Fumery, M.;
- Hébuterne, X.;
- Viennot, S.;
- Laharie, D.;
- Beaugerie, L.;
- Nancey, S.;
- Sokol, H.;
- Abitbol, Vered;
- Altwegg, Romain;
- Amiot, Aurélien;
- Beaugerie, Laurent
Publication type:
Article
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 310, doi. 10.1111/apt.14167
By:
- Amiot, A.;
- Serrero, M.;
- Peyrin‐Biroulet, L.;
- Filippi, J.;
- Pariente, B.;
- Roblin, X.;
- Buisson, A.;
- Stefanescu, C.;
- Trang‐Poisson, C.;
- Altwegg, R.;
- Marteau, P.;
- Vaysse, T.;
- Bourrier, A.;
- Nancey, S.;
- Laharie, D.;
- Allez, M.;
- Savoye, G.;
- Moreau, J.;
- Vuitton, L.;
- Viennot, S.
Publication type:
Article
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 2, p. 142, doi. 10.1111/apt.14106
By:
- Roblin, X.;
- Boschetti, G.;
- Williet, N.;
- Nancey, S.;
- Marotte, H.;
- Berger, A.;
- Phelip, J. M.;
- Peyrin‐Biroulet, L.;
- Colombel, J. F.;
- Del Tedesco, E.;
- Paul, S.;
- Flourie, B.
Publication type:
Article
Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 4, p. 443, doi. 10.1111/apt.12394
By:
- Nancey, S.;
- Boschetti, G.;
- Moussata, D.;
- Hequet, O.;
- Roblin, X.;
- Flourié, B.
Publication type:
Article
Letter: mucosal healing in ulcerative colitis - higher relevance than in Crohn's disease? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 208, doi. 10.1111/apt.12361
By:
- Laharie, D.;
- Filippi, J.;
- Roblin, X.;
- Nancey, S.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 10, p. 998, doi. 10.1111/apt.12289
By:
- Laharie, D.;
- Filippi, J.;
- Roblin, X.;
- Nancey, S.;
- Chevaux, J.‐B.;
- Hébuterne, X.;
- Flourié, B.;
- Capdepont, M.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Infliximab for refractory ulcerative proctitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 11, p. 1178, doi. 10.1111/j.1365-2036.2010.04293.x
By:
- BOUGUEN, G.;
- ROBLIN, X.;
- BOURREILLE, A.;
- FEIER, L.;
- FILIPPI, J.;
- NANCEY, S.;
- BRETAGNE, J.‐F.;
- FLOURIÉ, B.;
- HÉBUTERNE, X.;
- BIGARD, M.‐A.;
- SIPROUDHIS, L.;
- PEYRIN‐BIROULET, L.
Publication type:
Article
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.
Published in:
Journal of Crohn's & Colitis, 2022, v. 16, n. 10, p. 1523, doi. 10.1093/ecco-jcc/jjac061
By:
- Poullenot, F;
- Amiot, A;
- Nachury, M;
- Viennot, S;
- Altwegg, R;
- Bouhnik, Y;
- Abitbol, V;
- Nancey, S;
- Vuitton, L;
- Peyrin-Biroulet, L;
- Biron, A;
- Fumery, M;
- Picon, L;
- Vidon, M;
- Reenaers, C;
- Serrero, M;
- Savoye, G;
- Beaugerie, L;
- Rivière, P;
- Laharie, D
Publication type:
Article
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.
Published in:
Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1202, doi. 10.1093/ecco-jcc/jjac035
By:
- Cottron, C;
- Treton, X;
- Altwegg, R;
- Reenaers, C;
- Amiot, A;
- Fumery, M;
- Vuitton, L;
- Peyrin-Biroulet, L;
- Bouguen, G;
- Dewit, O;
- Nancey, S;
- Caillo, L;
- Roblin, X;
- Beylot-Barry, M;
- Rivière, P;
- Laharie, D
Publication type:
Article
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID.
Published in:
Journal of Crohn's & Colitis, 2021, v. 15, n. 6, p. 1000, doi. 10.1093/ecco-jcc/jjaa250
By:
- Buisson, A;
- Filippi, J;
- Amiot, A;
- Cadiot, G;
- Allez, M;
- Marteau, P;
- Bouhnik, Y;
- Chambrun, G Pineton de;
- Pelletier, A L;
- Nancey, S;
- Moussata, D;
- Attar, A;
- Blain, A;
- Vuitton, L;
- Vernier-Massouille, G;
- Seksik, P;
- Nachury, M;
- Dupas, J L;
- Laharie, D;
- Peyrin-Biroulet, L
Publication type:
Article
Segmental Colectomy for Ulcerative Colitis: Is There a Place in Selected Patients Without Active Colitis? An International Multicentric Retrospective Study in 72 Patients.
Published in:
Journal of Crohn's & Colitis, 2020, v. 14, n. 12, p. 1687, doi. 10.1093/ecco-jcc/jjaa107
By:
- Frontali, A;
- Cohen, L;
- Bridoux, V;
- Myrelid, P;
- Sica, G;
- Poggioli, Gilberto;
- Espin, E;
- Beyer-Berjot, L;
- Laharie, D;
- Spinelli, A;
- Zerbib, P;
- Sampietro, G;
- Frasson, M;
- Louis, E;
- Danese, S;
- Fumery, M;
- Denost, Q;
- Altwegg, R;
- Nancey, S;
- Michelassi, F
Publication type:
Article
Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.
Published in:
Journal of Crohn's & Colitis, 2017, v. 11, n. 1, p. 47, doi. 10.1093/ecco-jcc/jjw123
By:
- Simon, M.;
- Cosnes, J.;
- Gornet, J. M.;
- Seksik, P.;
- Stefanescu, C.;
- Blain, A.;
- Pariente, B.;
- Nancey, S.;
- Vuitton, L.;
- Nachury, M.;
- D'Haens, G.;
- Filippi, J.;
- Chevret, S.;
- Laharie, D.
Publication type:
Article
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.
Published in:
Journal of Crohn's & Colitis, 2016, v. 10, n. 4, p. 395, doi. 10.1093/ecco-jcc/jjv227
By:
- Marthey, L.;
- Mateus, C.;
- Mussini, C.;
- Nachury, M.;
- Nancey, S.;
- Grange, F.;
- Zallot, C.;
- Peyrin-Biroulet, L.;
- Rahier, J. F.;
- de Beauregard, M. Bourdier;
- Mortier, L.;
- Coutzac, C.;
- Soularue, E.;
- Lanoy, E.;
- Kapel, N.;
- Planchard, D.;
- Chaput, N.;
- Robert, C.;
- Carbonnel, F.
Publication type:
Article
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 6, p. 445, doi. 10.1093/ecco-jcc/jjv063
By:
- Paul, S.;
- Boschetti, G.;
- Rinaudo-Gaujous, M.;
- Moreau, A.;
- Del Tedesco, E.;
- Bonneau, J.;
- Presles, E.;
- Mounsef, F.;
- Clavel, L.;
- Genin, C.;
- Flourié, B.;
- Phelip, J.-M.;
- Nancey, S.;
- Roblin, X.
Publication type:
Article
Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 3, p. 252, doi. 10.1093/ecco-jcc/jjv001
By:
- Filippi, J.;
- Laharie, D.;
- Michiels, C.;
- Flamand, M.;
- Bouguen, G.;
- Nancey, S.;
- Presles, E.;
- Paul, S.;
- Schneider, S.;
- Hébuterne, X.;
- Roblin, X.
Publication type:
Article
What dermatologists should know about faecal calprotectin to allow adequate interpretation of the results in clinical practice.
Published in:
Clinical & Experimental Dermatology, 2021, v. 46, n. 4, p. 742, doi. 10.1111/ced.14544
By:
- Nancey, S.;
- Flourié, B.;
- Gay, C.;
- Boschetti, G.
Publication type:
Article

Found: 23